Fidelity International’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-218,705
| Closed | -$209K | – | 974 |
|
|
2024
Q4 | $209K | Hold |
218,705
| – | – | ﹤0.01% | 819 |
|
|
2024
Q3 | $172K | Hold |
218,705
| – | – | ﹤0.01% | 829 |
|
|
2024
Q2 | $207K | Hold |
218,705
| – | – | ﹤0.01% | 788 |
|
|
2024
Q1 | $236K | Hold |
218,705
| – | – | ﹤0.01% | 790 |
|
|
2023
Q4 | $120K | Hold |
218,705
| – | – | ﹤0.01% | 767 |
|
|
2023
Q3 | $461K | Hold |
218,705
| – | – | ﹤0.01% | 723 |
|
|
2023
Q2 | $573K | Hold |
218,705
| – | – | ﹤0.01% | 710 |
|
|
2023
Q1 | $695K | Hold |
218,705
| – | – | ﹤0.01% | 731 |
|
|
2022
Q4 | $588K | Hold |
218,705
| – | – | ﹤0.01% | 733 |
|
|
2022
Q3 | $636K | Hold |
218,705
| – | – | ﹤0.01% | 737 |
|
|
2022
Q2 | $639K | Hold |
218,705
| – | – | ﹤0.01% | 741 |
|
|
2022
Q1 | $1.55M | Hold |
218,705
| – | – | ﹤0.01% | 705 |
|
|
2021
Q4 | $3.5M | Buy |
+218,705
| New | +$3.5M | ﹤0.01% | 640 |
|